Best-Selling Research Peptides in Canada

Peptides

Retatrutide 10 mg

Triple GIP / GLP-1 / Glucagon Agonist · 10, 20, 40 & 120 mg Retatrutide is a synthetic peptide developed for controlled laboratory research involving multi-receptor signaling systems. It is structurally designed to interact with GLP-1, GIP, and glucagon receptor pathways within experimental environments.

RETA-CA-26F-1099.637%

11.76 mg / 10 mg

Peptides

Tirzepatide 10 mg

Dual GIP / GLP-1 Agonist · 10, 30 & 65 mg Tirzepatide is a synthetic peptide developed for controlled laboratory research involving dual incretin receptor signaling systems. It is structurally designed to interact with GLP-1 and GIP receptor pathways within experimental environments.

TIRZ-CA-26G-1099.634%

11.42 mg / 10 mg

Peptides

Semaglutide 10 mg

GLP-1 Receptor Agonist · 10 mg Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in glucose-dependent signaling. It is developed for controlled laboratory investigation within regulated experimental environments.

SEMA-CA-26F-1099.504%

11.27 mg / 10 mg

Peptides

Cagrilintide 5 mg

Long-Acting Amylin Analogue · 5 & 10 mg Cagrilintide is a synthetic peptide developed for controlled laboratory research involving amylin receptor signaling systems. It is structurally designed to interact with amylin-associated pathways within experimental environments.

CAG-CA-26A-0199.446%

5.62 mg / 5 mg

Peptides

BPC-157 10 mg

Body Protection Compound Pentadecapeptide · 10 mg BPC-157 is a synthetic peptide derived from a fragment of a naturally occurring gastric protein. It is produced for laboratory research and studied within controlled experimental environments.

BPC-CA-26F-1099.765%

10.98 mg / 10 mg

Peptides

TB-500 10 mg

Thymosin Beta-4 Fragment Research Peptide TB-500 is a synthetic research peptide modeled after thymosin beta-4, a naturally occurring peptide involved in cellular signaling processes. It is developed for controlled laboratory investigation within regulated experimental environments.

TB5-CA-26F-1099.182%

11.52 mg / 10 mg

Peptides

KPV 10 mg

Tripeptide Research Compound KPV is a synthetic tripeptide composed of lysine–proline–valine and represents a fragment derived from the alpha-melanocyte–stimulating hormone (α-MSH) sequence. It is developed for controlled laboratory research involving peptide-mediated signaling systems.

KPV-CA-26I-1099.103%

11.56 mg / 10 mg

Intranasal Sprays

Wolverine Stack Spray

Multi-Peptide Blend Preparation "Wolverine Stack Spray" is a trade designation for a combination preparation sold in the research-chemical market rather than a defined chemical entity. There is no entry for the name in public chemical registries, and no standardized composition is documented in the published literature.

BPCT-CA-26F-01

BPC-157 6.25 mg / TB-500 (TB4) 5.86 mg

Peptides

Deadpool Blend 20 mg

Recovery Blend Deadpool is a research blend supplying cartalax, BPC-157, and TB-500 in a single vial.

CTBT-CA-26F-20

Cartalax 10.72 mg / BPC-157 5.98 mg / TB-500 (TB4) 5.75 mg / 20 mg

Peptides

Coremend Blend 45 mg

TB-500 / BPC-157 / KPV Recovery Blend Coremend is a research blend combining TB-500 (thymosin beta-4 fragment), BPC-157, and the tripeptide KPV in a single preparation, studied for converging tissue-repair and inflammatory-signaling pathways.

CORE-CA-26H-45

KPV 11.30 mg / BPC-157 11.85 mg / TB-500 (TB4) 26.93 mg / 45 mg

Bioregulators

Cartalax 20 mg

Cartilage-Derived Peptide Research Compound Cartalax is a synthetic peptide complex derived from cartilage-associated protein fractions and is developed for controlled laboratory research involving connective tissue signaling systems.

CART-CA-26F-2099.784%

20.64 mg / 20 mg

Peptides

KLOW Blend 80 mg

Multi-Peptide Research Blend KLOW is a multi-peptide research blend integrating GHK-Cu, BPC-157, TB-500, and KPV into a unified formulation developed for controlled laboratory investigation.

KLOW-CA-26G-01

GHK-Cu 63.68 mg / TB-500 (TB4) 11.30 mg / BPC-157 12.11 mg / KPV 10.92 mg / 80 mg

Peptides

GLOW Blend 70 mg

Multi-Peptide Research Blend GLOW is a multi-peptide research blend formulated for controlled laboratory investigation. It integrates GHK-Cu, BPC-157, and TB-500 into a single experimental compound.

GLOW-CA-26F-70

GHK-Cu 63.75 mg / TB-500 (TB4) 11.64 mg / BPC-157 12.16 mg / 70 mg

Cosmetics

GHK-Cu 50 mg

Copper Peptide Research Compound GHK-Cu is a synthetic copper-binding tripeptide composed of glycine, histidine, and lysine complexed with copper ions. It is developed for controlled laboratory research involving peptide–metal interaction systems.

GHK-CA-26A-0299.835%

61.87 mg / 50 mg

Aminos

NAD+ 500 mg

Nicotinamide Adenine Dinucleotide Research Compound NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in all living cells and plays a central role in cellular redox reactions. It is supplied for controlled laboratory research involving metabolic and mitochondrial signaling systems.

NAD-CA-26F-500

512.17 mg / 500 mg

Peptides

MOTS-c 10 mg

Mitochondrial-Derived Peptide MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondrial-derived peptide identified through genomic analysis of mitochondrial DNA. It is synthesized for controlled laboratory research and studied within experimental environments focused on cellular and metabolic signaling.

MOTS-CA-26F-1098.683%

11.20 mg / 10 mg

Peptides

SS-31 50 mg

Mitochondria-Targeted Peptide Research Compound SS-31 is a synthetic tetrapeptide designed for controlled laboratory research involving mitochondrial-associated signaling systems. It is also known in scientific literature as elamipretide.

SS31-CA-26F-5099.768%

50.86 mg / 50 mg

Peptides

5-Amino-1MQ 10 mg

Nicotinamide N-Methyltransferase (NNMT) Inhibitor Research Compound 5-Amino-1MQ is a small-molecule research compound studied as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolic regulation. It is developed for controlled laboratory investigation within experimental environments.

51Q-CA-26A-0199.55%

11.17 mg / 10 mg

Intranasal Sprays

Mito Genesis Spray

Proprietary Blended Preparation Mito Genesis Spray is a proprietary blended preparation supplied as a spray-format laboratory material. It is not a single defined chemical entity with an established identity in the chemical literature, and no PubChem record corresponds to this name.

MITO-CA-26F-120

NAD+ 99.22 mg / MOTS-c 11.43 mg / 5-Amino-1MQ 11.14 mg

Peptides

Humanin 10 mg

Mitochondrial-Derived Peptide Humanin is a 24-residue peptide encoded within the mitochondrial genome, studied in research on cytoprotection and apoptosis-related signaling.

Peptides

Tesamorelin 10 mg

GHRH Analogue Research Peptide Tesamorelin is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH). It is developed for controlled laboratory research involving hypothalamic-pituitary signaling systems.

TESA-CA-26F-1098.763%

11.68 mg / 10 mg

Peptides

Tesamorelin / Ipamorelin Blend 13 mg

Tesamorelin / Ipamorelin GH-Axis Blend The Tesamorelin + Ipamorelin blend combines a GHRH analogue (Tesamorelin) with a selective ghrelin-receptor agonist (Ipamorelin), studied for complementary stimulation of the GH/IGF-1 axis.

TIPA-CA-26G-13

Tesamorelin 10.87 mg / Ipamorelin 3.53 mg / 13 mg

Peptides

Triad-GH Blend 12 mg

Growth Hormone Secretagogue Blend Triad-GH is a research blend supplying tesamorelin, ipamorelin, and CJC-1295 (No DAC) in a single vial.

TICA-CA-26G-12

Tesamorelin 6.74 mg / Ipamorelin 3.61 mg / CJC-1295 (mod GRF 1-29) 3.76 mg / 12 mg

Peptides

CJC-1295 / Ipamorelin Blend 10 mg

Dual GHRH / GHS-R Research Blend CJC-1295 + Ipamorelin is a dual-peptide research formulation combining a growth hormone–releasing hormone (GHRH) analogue with a selective ghrelin receptor (GHS-R1a) agonist. It is developed for controlled laboratory investigation involving hypothalamic-pituitary signaling systems.

CJIP-CA-26F-10

CJC-1295 (mod GRF 1-29) 5.57 mg / Ipamorelin 5.88 mg / 10 mg